Pearlman Cancer Center — Valdosta, Georgia

Pearlman Cancer Center is a clinical research site located in Valdosta, Georgia, United States 31602.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Pearlman Cancer Center has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Triple Negative Breast Cancer, Non Small Cell Lung Cancer (NSCLC).

Sponsors: Gilead Sciences, Bristol-Myers Squibb.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Valdosta

Browse all research sites in Georgia · View every site in Valdosta

• South Georgia Medical Center/Pearlman Cancer Center
• Pearlman Comprehensive Cancer Center at South Georgia Medical Center
• South Georgia Medical Center
• Medster Research
• Research Site
• GNP Research
• Valdosta Specialty Clinic
• Lowndes County
• Local Institute
• Valdosta Psychiatric Associates LLC
• 502.373.0162 Boehringer Ingelheim Investigational Site

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Pearlman Cancer Center?

Pearlman Cancer Center has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Pearlman Cancer Center conducted?

Pearlman Cancer Center has 2 clinical trials on record, with 1 currently active. Their work covers Triple Negative Breast Cancer, Non Small Cell Lung Cancer (NSCLC).

Is Pearlman Cancer Center accredited by Crixeo Clinical Trials?

Pearlman Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Pearlman Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.